Vistide

Active Ingredient(s): Cidofovir
FDA Approved: * June 26, 1996
Pharm Company: * GILEAD
Category: HIV / AIDS

Cidofovir, brand name Vistide, is an injectable antiviral medication primarily used as a treatment for cytomegalovirus (CMV) retinitis (an infection of the retina of the eye) in people with AIDS.[2][3] Cidofovir was approved for medical use in 1996.[4] Contents 1 Medical use 1.1 DNA virus 1.2 Other 2 Administration 3 Side effects 3.1 Contraindications 3.2 Interactions 4 Mechanism of action 5 History 6 Synthesis 7 See also 8 References ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vistide 75 mg/ml Intravenous Injection
NDC: 61958-0101
Labeler:
Gilead Sciences, Inc.

Related Brands

Drugs with the same active ingredients